EGFR and triple-negative breast carcinoma: Mechanistic alignment with tumor vulnerabilities—including redox addiction, ferroptosis resistance, and immune evasion—supports its relevance for triple-negative breast cancer (TNBC) and EGFR-mutant NSCLC [94,95].